EUROPEAN MARKETS FOR PROSTHETIC VASCULAR GRAFTS

360 Pages | 141 Exhibits | 2006 Analysis | Forecasts Through 2011

OVERVIEW:

In Europe, more than 4.35 million deaths are attributable to cardiovascular disease (CVD) each year, while more than 48 million adults in the region live with diabetes, a condition that not only substantially increases the risk of CVD, but also is the most common cause of kidney failure.

Patients with advanced CVD that results in vascular occlusion, those with aneurysms requiring repair, as well those receiving hemodialysis to manage kidney failure, often undergo prosthetic vascular graft implantation. Sales of prosthetic vascular grafts in Europe reached approximately $342.8 million in 2005. Growing at a steady compound annual rate of 5.7%, sales of these products are projected to climb to $478.6 million in the year 2011.

This dynamic report from Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in European markets for prosthetic vascular grafts.

Covered topics in this report include coronary artery bypass grafting procedures; coronary heart disease statistics; diabetes statistics; endovascular stent-graft systems for aortic aneurysm repair; European population statistics; expanded polytetrafluoroethylene grafts; hemodialysis access grafts; overviews of selected European national healthcare markets; polyester grafts; polyurethane grafts; prosthetic vascular graft applications; peripheral vascular grafts; sales of abdominal and thoracic aortic aneurysm endovascular stent-grafts in Europe; sales of hemodialysis access grafts in Europe; sales of peripheral vascular grafts in Europe; sales of small-diameter coronary artery bypass grafts in Europe; and stroke disability and mortality and other disease/disorder statistics.

TABLE OF CONTENTS:

EXECUTIVE SUMMARY

i.   Market Drivers

ii.   Market Limiters

iii.  Overall European Market for Prosthetic Vascular Grafts

a.  Hemodialysis Access Grafts Market

b.  Aortic Aneurysm Endovascular Stent-Graft Systems Market

c.  Peripheral Vascular Grafts Market

d.  Small-Diameter Coronary Artery Bypass Grafts

iv.  Methodology

 

Exhibit ES-1:    Prosthetic Vascular Grafts, Indications for Use

Exhibit ES-2:    Europe, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit ES-3:    France, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit ES-4:    Germany, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit ES-5:    Italy, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit ES-6:    Spain, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit ES-7:    United Kingdom, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit ES-8:    Benelux Countries, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit ES-9:    Nordic Countries, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit ES-10:   Rest of Europe, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit ES-11:   Europe, Hemodialysis Access Grafts, Market Forecast, 2001-2011

Exhibit ES-12:   Europe, Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Market Forecast, 2001-2011

Exhibit ES-13:   Europe, Peripheral Vascular Grafts, Market Forecast, 2001-2011

Exhibit ES-14:   Europe, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, 2001-2011

 

1. OVERVIEW OF SELECTED EUROPEAN HEALTHCARE MARKETS

1.1 The European Union

1.1.1 A Common Currency

1.1.2 Regulatory Policies

1.1.3 Reimbursement

1.1.4 Healthcare Spending

1.2 Selected European National Healthcare Profiles

1.2.1 France

1.2.1.1 Healthcare Organization and Reform

1.2.1.2 Hospital Services

1.2.1.3 Medical Device Reimbursement

1.2.2 Germany

1.2.2.1 Healthcare Organization and Reform

1.2.2.2 Hospital Services

1.2.2.3 Medical Device Reimbursement

1.2.3 Italy

1.2.3.1 Healthcare Organization and Reform

1.2.3.2 Hospital Services

1.2.3.3 Medical Device Reimbursement

1.2.4 Spain

1.2.4.1 Healthcare Organization and Reform

1.2.4.2 Hospital Services

1.2.4.3 Medical Device Reimbursement

1.2.5 United Kingdom

1.2.5.1 Healthcare Organization and Reform

1.2.5.2 Hospital Services

1.2.5.3 Medical Device Reimbursement

1.2.6 Benelux

1.2.6.1 Healthcare Organization and Reform

1.2.6.1.1 Belgium

1.2.6.1.2 Luxembourg

1.2.6.1.3 The Netherlands

1.2.6.2 Hospital Services

1.2.6.3 Medical Device Reimbursement

1.2.7 Nordic Countries

1.2.7.1 Healthcare Organization and Reform

1.2.7.1.1 Denmark

1.2.7.1.2 Finland

1.2.7.1.3 Norway

1.2.7.1.4 Sweden

1.2.7.2 Hospital Services

1.2.7.3 Medical Device Reimbursement

 

Exhibit 1-1:      European Union, Medical Devices Risk Classification System

Exhibit 1-2:      European Union, Population Statistics Comparison, 1995 and 2005

Exhibit 1-3:      France, Selected National Healthcare Statistics

Exhibit 1-4:      Germany, Selected National Healthcare Statistics

Exhibit 1-5:      Italy, Selected National Healthcare Statistics

Exhibit 1-6:      Spain, Selected National Healthcare Statistics

Exhibit 1-7:      United Kingdom, Selected National Healthcare Statistics

Exhibit 1-8:      Belgium, Selected National Healthcare Statistics

Exhibit 1-9:      Luxembourg, Selected National Healthcare Statistics

Exhibit 1-10:     Netherlands, Selected National Healthcare Statistics

Exhibit 1-11:     Denmark, Selected National Healthcare Statistics

Exhibit 1-12:     Finland, Selected National Healthcare Statistics

Exhibit 1-13:     Norway, Selected National Healthcare Statistics

Exhibit 1-14:     Sweden, Selected National Healthcare Statistics

 

2. OVERVIEW OF SELECTED CARDIOVASCULAR DISEASES/DISORDERS

2.1 Cardiovascular Diseases/Disorders

2.1.1 Coronary Heart Disease

2.1.1.1 Atherosclerosis

2.1.1.1.1 Description

2.1.1.1.2 Statistics

2.1.1.2 Angina Pectoris

2.1.1.2.1 Description

2.1.1.2.2 Statistics

2.1.1.3 Myocardial Infarction

2.1.1.3.1 Description

2.1.1.3.2 Statistics

2.1.2 Hypertension

2.1.2.1 Description

2.1.2.2 Statistics

2.1.3 Aneurysm

2.1.3.1 Description

2.1.3.2 Statistics

2.1.4 Stroke

2.1.4.1 Description

2.1.4.2 Statistics

2.1.5 Diabetes

2.1.5.1 Description

2.1.5.2 Statistics

2.2 Cardiovascular Disease Management Options

2.2.1 Medical Management

2.2.1.1 Lifestyle Changes

2.2.1.1.1 Diet Modification

2.2.1.1.2 Smoking Cessation

2.2.1.2 Pharmaceuticals

2.2.1.2.1 Anticoagulants and Antiplatelet Drugs

2.2.1.2.2 Lipid-Lowering Drugs

2.2.1.2.3 Anti-Hypertensive Drugs

2.2.1.2.4 Nitroglycerin Preparations

2.2.2 Intracoronary Heart Disease Diagnosis

2.2.2.1 Coronary Angiography

2.2.2.1.1 Description

2.2.2.1.2 Statistics

2.2.3 Surgical/Transcatheter-Based Interventions

2.2.3.1 Coronary Artery Bypass Graft Surgery

2.2.3.1.1 Description

2.2.3.1.2 Statistics

2.2.3.2 Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting

2.2.3.2.1 Description

2.2.3.2.2 Statistics

2.2.3.3 Percutaneous Transluminal Angioplasty and Peripheral Stenting

2.2.3.3.1 Description

2.2.3.3.2 Statistics

2.2.3.4 Prosthetic Vascular Grafting

2.2.3.4.1 Description

2.2.3.4.2 Statistics

 

Exhibit 2-1:      Men, Number of Deaths due to Cardiovascular Diseases/Disorders, Selected European Countries

Exhibit 2-2:      Women, Number of Deaths due to Cardiovascular Diseases/Disorders, Selected European Countries

Exhibit 2-3:      Europe, Total Cholesterol and High-Cholesterol Prevalence, Selected MONICA Project Populations, by Gender Group

Exhibit 2-4:      Standard Angina Pectoris Classification

Exhibit 2-5:      Europe, Coronary Events Incidence Rates, Selected MONICA Project Populations, by Gender Group

Exhibit 2-6:      Europe, Systolic Blood Pressure Levels, Selected MONICA Project Populations, by Gender Group

Exhibit 2-7:      Europe, Mean Systolic Blood Pressure Levels, Selected Countries, by Gender Group, 2002 and 2010

Exhibit 2-8:      Europe, Stroke Disability and Mortality, By Selected Country

Exhibit 2-9:      Europe, Estimated Number of People with Diabetes, Selected Countries, 2003 and 2025

Exhibit 2-10:     2001, Percentage of Coronary Heart Disease Patients Advised to Participate in Cardiac Rehabilitation, Selected Countries

Exhibit 2-11:     2001, Percentage of Total Energy Intake Provided by Fats and Fruits/Vegetables in the Populations of Selected European Countries

Exhibit 2-12:     2003, Percentage of Tobacco Smokers in Selected European Countries, by Gender Group

Exhibit 2-13:     Europe, Selected Pharmaceutical Preparations Prescribed for Hospital Patients with Coronary Heart Disease, by Geographic Region

Exhibit 2-14:     2004, Cardiac Catheterization Laboratories and Coronary Angiography Procedures, by European Country/Region

Exhibit 2-15:     Europe, Procedure Rates for Percutaneous Coronary Interventions Versus Coronary Artery Bypass Graft Surgeries, 2001-2011        

Exhibit 2-16:     2000, Open-Heart and Coronary Artery Bypass Graft Surgery, Procedure Rates per Million Population, Selected European Countries

Exhibit 2-17:     Europe, Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting, Historic and Forecast Procedures Volumes, 2001-2011

Exhibit 2-18:     Europe, Peripheral Vascular Stenting Procedures, 2004-2011

Exhibit 2-19:     Europe, Prosthetic Vascular Grafting Procedures, 2001-2011

 

3. THE EUROPEAN PROSTHETIC VASCULAR GRAFTS MARKET

3.1 Prosthetic Vascular Grafting Applications

3.1.1 Vascular Occlusion

3.1.2 Aneurysm

3.1.3 Kidney Failure

3.2 Prosthetic Vascular Graft Categorization

3.2.1 Categorization by Graft Diameter

3.2.1.1 Large-Diameter Grafts

3.2.1.2 Medium-Diameter Grafts

3.2.1.3 Small-Diameter Grafts

3.2.2 Categorization by Graft Material

3.2.2.1 Polyester

3.2.2.2 Polytetrafluoroethylene

3.2.2.3 Polyurethane

3.2.2.4 Biological

3.2.2.4.1 Human Saphenous and Umbilical Veins

3.2.2.4.2 Tissue-Engineered Materials

3.2.3 Endovascular Stent-Grafts

3.2.3.1 Performance Requirements

3.2.3.2 Configurations

3.2.3.3 Endovascular Stent-Graft-Related Complications

3.3 Prosthetic Vascular Grafts Market

3.3.1 Market Overview

3.3.1.1 Market Drivers

3.3.1.2 Market Limiters

3.3.1.3 National Markets

3.3.1.4 Competitors

3.3.2 Hemodialysis Access Grafts

3.3.2.1 Market Forecast

3.3.2.2 Competitive Analysis

3.3.3 Endovascular Stent-Graft Systems for Aortic Aneurysm Repair

3.3.3.1 Market Forecast

3.3.3.2 Competitive Analysis

3.3.4 Peripheral Vascular Grafts

3.3.4.1 Market Forecast

3.3.4.2 Competitive Analysis

3.3.5 Small-Diameter Coronary Artery Bypass Grafts

3.3.5.1 Market Forecast

3.3.5.2 Competitive Analysis

 

Exhibit 3-1:      Prosthetic Vascular Grafts, Indications for Use

Exhibit 3-2:      Interventions for the Treatment of Peripheral Vascular Occlusions

Exhibit 3-3:      1998, Europe, End-Stage Renal Failure Statistics, by Country

Exhibit 3-4:      Design Criteria for Synthetic Vascular Grafts

Exhibit 3-5:      Applications for Prosthetic Vascular Grafts, by Diameter

Exhibit 3-6:      2006, Selected Polyester Vascular Grafts

Exhibit 3-7:      2006, Selected Polytetrafluoroethylene Vascular Grafts

Exhibit 3-8:      2006, Selected Polyurethane Vascular Grafts

Exhibit 3-9:      Design Specifications for Endovascular Stent-Graft Systems

Exhibit 3-10:     Complications Associated with the Use of Endovascular Stent-Grafts for Abdominal Aortic Aneurysm Repair

Exhibit 3-11:     2006, Selected Current and Emerging Endovascular Stent-Graft Systems for Aortic Aneurysm Repair

Exhibit 3-12:     Europe, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-13:     Europe, Prosthetic Vascular Grafts Market Segment Revenues as a Percentage of Total Graft Revenues, 2001-2011

Exhibit 3-14:     France, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-15:     Germany, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-16:     Italy, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-17:     Spain, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-18:     United Kingdom, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-19:     Benelux Countries, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-20:     Nordic Countries, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-21:     Rest of Europe, Prosthetic Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-22:     2005, European Prosthetic Vascular Grafts Market, Share by Supplier

Exhibit 3-23:     Europe, Hemodialysis Access Grafts, Market Forecast, 2001-2011

Exhibit 3-24:     France, Hemodialysis Access Grafts, Market Forecast, 2001-2011

Exhibit 3-25:     Germany, Hemodialysis Access Grafts, Market Forecast, 2001-2011

Exhibit 3-26:     Italy, Hemodialysis Access Grafts, Market Forecast, 2001-2011

Exhibit 3-27:     Spain, Hemodialysis Access Grafts, Market Forecast, 2001-2011

Exhibit 3-28:     United Kingdom, Hemodialysis Access Grafts, Market Forecast, 2001-2011

Exhibit 3-29:     Benelux Countries, Hemodialysis Access Grafts, Market Forecast, 2001-2011

Exhibit 3-30:     Nordic Countries, Hemodialysis Access Grafts, Market Forecast, 2001-2011

Exhibit 3-31:     Rest of Europe, Hemodialysis Access Grafts, Market Forecast, 2001-2011

Exhibit 3-32:     2005, Europe, Hemodialysis Access Grafts Market, Share by Supplier

Exhibit 3-33:     2005, France, Hemodialysis Access Grafts Market, Share by Supplier

Exhibit 3-34:     2005, Germany, Hemodialysis Access Grafts Market, Share by Supplier

Exhibit 3-35:     2005, Italy, Hemodialysis Access Grafts Market, Share by Supplier

Exhibit 3-36:     2005, Spain, Hemodialysis Access Grafts Market, Share by Supplier

Exhibit 3-37:     2005, United Kingdom, Hemodialysis Access Grafts Market, Share by Supplier

Exhibit 3-38:     2005, Benelux Countries, Hemodialysis Access Grafts Market, Share by Supplier

Exhibit 3-39:     2005, Nordic Countries, Hemodialysis Access Grafts Market, Share by Supplier

Exhibit 3-40:     2005, Rest of Europe, Hemodialysis Access Grafts Market, Share by Supplier

Exhibit 3-41:     Europe, Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Market Forecast, 2001-2011

Exhibit 3-42:     France, Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Market Forecast, 2001-2011

Exhibit 3-43:     Germany, Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Market Forecast, 2001-2011

Exhibit 3-44:     Italy, Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Market Forecast, 2001-2011

Exhibit 3-45:     Spain, Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Market Forecast, 2001-2011

Exhibit 3-46:     United Kingdom, Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Market Forecast, 2001-2011

Exhibit 3-47:     Benelux Countries, Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Market Forecast, 2001-2011

Exhibit 3-48:     Nordic Countries, Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Market Forecast, 2001-2011

Exhibit 3-49:     Rest of Europe, Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Market Forecast, 2001-2011

Exhibit 3-50:     2005, Europe, Market for Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Share by Supplier

Exhibit 3-51:     2005, France, Market for Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Share by Supplier

Exhibit 3-52:     2005, Germany, Market for Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Share by Supplier

Exhibit 3-53:     2005, Italy, Market for Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Share by Supplier

Exhibit 3-54:     2005, Spain, Market for Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Share by Supplier

Exhibit 3-55:     2005, United Kingdom, Market for Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Share by Supplier

Exhibit 3-56:     2005, Benelux Countries, Market for Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Share by Supplier

Exhibit 3-57:     2005, Nordic Countries, Market for Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Share by Supplier

Exhibit 3-58:     2005, Rest of Europe, Market for Endovascular Stent-Graft Systems for Aortic Aneurysm Repair, Share by Supplier

Exhibit 3-59:     Europe, Peripheral Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-60:     France, Peripheral Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-61:     Germany, Peripheral Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-62:     Italy, Peripheral Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-63:     Spain, Peripheral Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-64:     United Kingdom, Peripheral Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-65:     Benelux Countries, Peripheral Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-66:     Nordic Countries, Peripheral Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-67:     Rest of Europe, Peripheral Vascular Grafts, Market Forecast, 2001-2011

Exhibit 3-68:     2005, Europe, Peripheral Vascular Grafts Market, Share by Supplier

Exhibit 3-69:     2005, France, Peripheral Vascular Grafts Market, Share by Supplier

Exhibit 3-70:     2005, Germany, Peripheral Vascular Grafts Market, Share by Supplier

Exhibit 3-71:     2005, Italy, Peripheral Vascular Grafts Market, Share by Supplier

Exhibit 3-72:     2005, Spain, Peripheral Vascular Grafts Market, Share by Supplier

Exhibit 3-73:     2005, United Kingdom, Peripheral Vascular Grafts Market, Share by Supplier

Exhibit 3-74:     2005, Benelux Countries, Peripheral Vascular Grafts Market, Share by Supplier

Exhibit 3-75:     2005, Nordic Countries, Peripheral Vascular Grafts Market, Share by Supplier

Exhibit 3-76:     2005, Rest of Europe, Peripheral Vascular Grafts Market, Share by Supplier

Exhibit 3-77:     Europe, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, 2001-2011

Exhibit 3-78:     France, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, 2001-2011

Exhibit 3-79:     Germany, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, 2001-2011

Exhibit 3-80:     Italy, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, 2001-2011

Exhibit 3-81:     Spain, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, 2001-2011

Exhibit 3-82:     United Kingdom, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, 2001-2011

Exhibit 3-83:     Benelux Countries, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, 2001-2011

Exhibit 3-84:     Nordic Countries, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, 2001-2011

Exhibit 3-85:     Rest of Europe, Small-Diameter Coronary Artery  Bypass Grafts, Market Forecast, 2001-2011

Exhibit 3-86:     2005, Europe, Small-Diameter Coronary Artery Bypass Grafts Market, Share by Supplier

Exhibit 3-87:     2005, France, Small-Diameter Coronary Artery Bypass Grafts Market, Share by Supplier

Exhibit 3-88:     2005, Germany, Small-Diameter Coronary Artery Bypass Grafts Market, Share by Supplier

Exhibit 3-89:     2005, Italy, Small-Diameter Coronary Artery Bypass Grafts Market, Share by Supplier

Exhibit 3-90:     2005, Spain, Small-Diameter Coronary Artery Bypass Grafts Market, Share by Supplier

Exhibit 3-91:     2005, United Kingdom, Small-Diameter Coronary Artery Bypass Grafts Market, Share by Supplier

Exhibit 3-92:     2005, Benelux Countries, Small-Diameter Coronary Artery Bypass Grafts Market, Share by Supplier

Exhibit 3-93:     2005, Nordic Countries, Small-Diameter Coronary Artery Bypass Grafts Market, Share by Supplier

Exhibit 3-94:     2005, Rest of Europe, Small-Diameter Coronary Artery Bypass Grafts Market, Share by Supplier

 

4. COMPANY PROFILES

4.1   C.R. Bard, Inc.

4.2   Boston Scientific Corporation

4.3   B. Braun Melsungen AG

4.4   Cook Group

4.5   Cordis Corporation/Johnson & Johnson

4.6   W. L. Gore & Associates, Inc.

4.7   InterVascular Corporation/Datascope Corporation

4.8   Medtronic, Inc.

4.9   Vascutek LTD/Terumo Corporation

COMPANIES COVERED:

1. C.R. Bard, Inc.
2. Boston Scientific Corporation
3. B. Braun Melsungen AG
4. Cook Group
5. Cordis Corporation/Johnson & Johnson
6. W. L. Gore & Associates, Inc.
7. InterVascular Corporation/Datascope Corporation
8. Medtronic, Inc.
9. Vascutek LTD/Terumo Corporation